Dr. Arepally is Professor of Medicine and Vice Chief of Research in the Division of Hematology at Duke University Medical Center. Her career has focused on immune thrombocytopenias, thrombotic disorders, and applications of therapeutic apheresis for immunologic disorders. Dr. Arepally’s long-standing research program investigates immunoregulatory mechanisms in HIT, research that led to the discovery of the role of complement activation in the immune pathogenesis of HIT. Dr. Arepally received her MD from Vanderbilt University, completed residency in Internal Medicine at Emory University where she was Chief Medical Resident and finished subspecialty training in Hematology/Oncology at the University of Pennsylvania.